CN106046095B - Synthetic method of 6-ethylchenodeoxycholic acid - Google Patents

Synthetic method of 6-ethylchenodeoxycholic acid Download PDF

Info

Publication number
CN106046095B
CN106046095B CN201610394654.6A CN201610394654A CN106046095B CN 106046095 B CN106046095 B CN 106046095B CN 201610394654 A CN201610394654 A CN 201610394654A CN 106046095 B CN106046095 B CN 106046095B
Authority
CN
China
Prior art keywords
compound
formula
reaction
acid
carry out
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610394654.6A
Other languages
Chinese (zh)
Other versions
CN106046095A (en
Inventor
姚绎炎
杜杨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN201610394654.6A priority Critical patent/CN106046095B/en
Publication of CN106046095A publication Critical patent/CN106046095A/en
Application granted granted Critical
Publication of CN106046095B publication Critical patent/CN106046095B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Abstract

The invention discloses a synthetic method of 6-ethylchenodeoxycholic acid. The synthetic method comprises steps as follows: chenodeoxycholic acid and an oxidizing agent are subjected to an oxidizing reaction and an esterification reaction, and a compound with a structure represented as a formula III is prepared; hydroxyl and carbonyl on rings of the compound with the structure represented as the formula III are protected with tert-butyldimethylsilyl chloride, and a compound with a structure represented as a formula IV is obtained; the compound with the structure represented as the formula IV and paraldehydeare are subjected to an electrophilic addition reaction and then are subjected to deprotection, and a compound with a structure represented as a formula V is obtained; the compound with the structure represented as the formula V is subjected to catalytic hydrogenation and is subjected to reduction and hydrolysis finally, and the compound 6-ethylchenodeoxycholic acid with a structure represented as a formula VI is obtained. The method is simple and convenient to operate, adopts mild conditions, has higher yield and is suitable for being popularized to industrial production.

Description

The synthetic method of shellfish cholic acid difficult to understand
Technical field
The invention belongs to pharmaceutical synthesis field and in particular to a kind of Austria shellfish cholic acid (6- ethyl chenodeoxycholic acid) synthesis work Skill.
Background technology
Liver cirrhosis is clinical common chronic progressive external hepatopathy, is that for a long time or repeated action is formed one or more cause of disease Diffusivity hepatic lesion.Non-alcohol fatty liver is the new challenge in contemporary medical science field, non-alcoholic fatty liver at no distant date Disease will be continuously increased to the harm of human health.Shellfish cholic acid difficult to understand belongs to farnesoid X receptor agonist, is subject to by activating farnesol X Body, the gene expression of suppression cytochrome 7A1 (CYP7A1) indirectly.Because CYP7A1 is the biosynthetic rate-limiting enzyme of cholic acid, because This shellfish cholic acid difficult to understand can promote cholic acid to synthesize, for treating primary biliary cirrhosiss and non-alcohol fatty liver.
At present, shellfish cholic acid difficult to understand is still in clinical trial, fail large scale investment production application it is known that method in use The highly basic such as LDA prepare intermediate, this kind of method expensive starting materials and the strict anhydrous and oxygen-free low temperature environment of needs;Make in subsequent step With this nucleopilic reagent of acetaldehyde, low boiling point, easily it is polymerized, complex operation, is unfavorable for industrialized production.
Content of the invention
The invention aims to solution severe reaction conditions, yield is not high, the problems such as synthetic route is immature, provides A kind of synthetic method of Austria shellfish cholic acid, this method is easy and simple to handle, mild condition, and yield is higher, is suitable for extending to industrial metaplasia Produce.
The purpose of the present invention can be reached by following measures:
A kind of synthetic method of Austria shellfish cholic acid, it comprises the steps:
(1) chenodeoxycholic acid and oxidant carry out oxidation reaction and obtain compound (II), then carry out esterification formula III compound 3 α-carboxyl -7 ketone -5 β cholestane -24- acid methyl ester;
(2) with tert-butyl chloro-silicane, protection is carried out to the hydroxyl on formula III compound ring and carbonyl and obtain formula IV Compound;
(3) formula IV compound and paraldehydum carry out electrophilic addition reaction, then obtain after deprotection Formula V compound 3 α- Hydroxyl -6- ethylidene -7- ketone -5 β-cholanic acid -24- methyl ester;
(4) Formula V compound carries out catalytic hydrogenation, finally carries out reduction and hydrolysis obtain Formula IV compound Austria shellfish gallbladder Acid;
Hereinafter each step of the present invention is elaborated.
Step (1), chenodeoxycholic acid and oxidant carry out oxidation reaction and obtain compound (II), then carry out esterification system Standby formula III compound 3 α-carboxyl -7 ketone -5 β cholestane -24- acid methyl ester;
In the oxidation reaction, how optionally to aoxidize the hydroxyl on 7 allows the hydroxyl of 3 not react being simultaneously Relatively more crucial problem in compound (II) synthesis, therefore in oxidation reaction from specific oxidant, be chosen in particular from NBS, One or more of PCC, chromic acid, experiment finds permissible when being oxidant using NBS (N-bromosuccinimide) Reach optimal oxidation effectiveness.
The temperature of this oxidation reaction is 20~30 DEG C, and the solvent of oxidation reaction is acetone water mixed solvent.
Esterification compound of formula H and methanol carry out esterification, add sulphuric acid, reaction temperature 55~65 in reaction ℃.Make the alcohol in esterification using methanol in experimental verification, this reaction, compare compared with other alcohol, such as ethanol, more readily soluble Solution, in addition methanol boiling point is also lower, is easier to remove during post processing.
In the reaction, chenodeoxycholic acid and the mol ratio of oxidant are 1:1~2, preferably 1:1.5.
Step (2), carries out protection with tert-butyl chloro-silicane to the hydroxyl on formula III compound ring and carbonyl and obtains Formula IV compound;
In the reaction that hydroxyl and carbonyl are protected, using tert-butyl chloro-silicane, it reacts bar to the present invention Part is gentle, and yield is high, sloughs simplicity.But tert-butyl chloro-silicane is met water and can be generated hydrogen chloride, therefore will ensure to react The drying of container when carrying out, in addition this blocking group excessively easily slough, if therefore reaction condition control not good; could be serious Impact yield.
Using lithium diisopropylamine (LDA) typically can be used during tert-butyl chloro-silicane as pulling out hydrogen, form carbon The alkali of anion, but during using LDA, must assure that anhydrous and oxygen-free environment, and must carry out at -78 DEG C to ensure the peace reacted Entirely carry out, operating difficultiess, high cost.The method using being added without LDA for the present invention, is controlled so that in room by suitable condition React under the conditions of temperature and also obtained the higher compound of yield (IV).
In the reaction of this step, formula III compound and tert-butyl chloro-silicane and imidazoles are in the effect of acid binding agent Under reacted, reaction temperature be 20~30 DEG C, reaction dissolvent be oxolane.Described acid binding agent can using pyridine, triethylamine, Triethanolamine, N, accelerine, N,N-dimethylformamide etc.;But it was found that, suitable acid binding agent and its use Amount is also to improve the key factor of reaction yield;The present invention through experimental verification when using triethylamine as acid binding agent and The mole of acid binding agent is 1.6~2.5 with the amount ratio with compound III:When 1, or more preferably adopt 2:When 1, Ke Yida To optimal reaction effect.
In the reaction, formula III compound and the mol ratio of tert-butyl chloro-silicane are 1:1.5~3.5, preferably 1: 2~3, most preferably 1:2.2.
Step (3), formula IV compound and paraldehydum carry out electrophilic addition reaction, then obtain Formula V chemical combination after deprotection Thing 3 Alpha-hydroxy -6- ethylidene -7- ketone -5 β-cholanic acid -24- methyl ester,
Formula IV compound carries out electrophilic addition reaction, after reaction with paraldehydum and boron trifluoride diethyl etherate at -35~0 DEG C Add tetrabutyl ammonium fluoride to carry out deprotection reaction at 0~30 DEG C, obtain Formula V compound.
In electrophilic addition reaction, it is used paraldehydum to add reaction as aldehyde precursors, paraldehydum is stable, and it is strong Under acid condition, depolymerization is acetaldehyde, and in this reaction, boron trifluoride diethyl etherate is strong Lewis acid, can make to generate acetaldehyde in reaction, from And avoid acetaldehyde and preserve difficult, the not high problem of purity.The synthesis of compound (V) is key one step preparing shellfish cholic acid difficult to understand, The carbon of the positively charged on 6 carbanion attack acetaldehyde, allows the oxygen on acetaldehyde remove the group of attack positively charged in reaction, thus de- Remove a molecular water, generate double bond, so needing Lewis acid to participate in reaction provide positive charged group.Therefore select suitable Lewis acid Particularly significant to the yield improving compound (V).
Lewis acid used in this reaction is selected from aluminum chloride, iron chloride or boron trifluoride diethyl etherate, but experiment finds, When Lewis acid is done using boron trifluoride diethyl etherate, higher yield can be obtained.Based on the characteristic of boron trifluoride diethyl etherate, concrete It is ensured that carrying out in anhydrous condition during use.
The solvent of this electrophilic addition reaction can be selected for dichloromethane.
In this step, formula IV compound and the mol ratio of paraldehydum, boron trifluoride diethyl etherate and tetrabutyl ammonium fluoride are 1:4~6:3~5:0.5~2.
Step (4), Formula V compound carries out catalytic hydrogenation, finally carries out reduction and hydrolysis obtain Formula IV compound Austria Shellfish cholic acid,
Formula V compound carries out hydrogenation reaction under palladium carbon catalysis, and reaction temperature is 20~30 DEG C, and reaction dissolvent can be selected for ice Acetic acid;Carry out reduction reaction in 20~30 DEG C in the presence of reducing agent after hydrogenation reaction, be eventually adding sodium hydroxide in 90~ Be hydrolyzed at 110 DEG C reaction, obtains shellfish cholic acid difficult to understand.
Formula V compound, after the step completing catalytic hydrogenation, needs 7 carbonyls optionally to be reduced, therefore Select suitable go back original reagent very crucial, reducing agent can be real using sodium borohydride, potassium borohydride, stannous chloride or lithium aluminium hydride reduction Issue after examination and approval existing, higher reduction effect can be reached when reducing agent is using sodium borohydride.Formula V compound and the mol ratio of reducing agent For 1:5~8, experiment finds that when mol ratio be 1:Optimal yield can be reached when 6.
, with chenodeoxycholic acid as raw material, oxidized, esterification, electrophilic addition, catalytic hydrogenation, reductive hydrolysis 5 step are anti-for the present invention 6- ethyl chenodeoxycholic acid (shellfish cholic acid difficult to understand) should be obtained, total recovery reaches 40%.Its structure warp1HNMR, MS analysis and testing technology is true Recognize.The method has following characteristics:
(1) dangerous substances such as LDA are not used, reaction condition is gentle, improves the low temperature environment in document, and in addition to hydrogenation All can carry out at ambient pressure, easy and simple to handle, equipment requirements are low, suitable laboratory is prepared and industrialized production;
(2) use paraldehydum as aldehyde precursors, solve the problem that acetaldehyde purity is not high, is difficult to preserve;
(3) often step product isolate and purify easier, single step yield is all higher with gross production rate;
(4) reaction needed raw material all can be by industrialized production, cheap easy acquisition.
Specific embodiment
With reference to embodiments the present invention is described further, but protection scope of the present invention be not limited to following each Embodiment.
Reagent and instrument
Chenodeoxycholic acid (98%, Hubei Yuancheng Saichuang Technology Co., Ltd.);Tert-butyl chloro-silicane, imidazoles, four Butyl ammonium fluoride, paraldehydum (GC, Shanghai Aladdin biochemical technology limited company);N-bromosuccinimide, tetrahydrochysene Furan, triethylamine (AR, Chengdu Ke Long chemical reagent factory);Boron trifluoride diethyl etherate (CP, Chengdu Ke Long chemical reagent factory);Boron Sodium hydride, sulphuric acid, hydrochloric acid, 10% (mass fraction) palladium carbon, remaining reagent is AR.
X-5 micro melting point apparatus (temperature control type) (Nanjing Jia Meilun scientific instrument company limited), not calibrated.Bruker Avance III (500MHz) nuclear magnetic resonance chemical analyser (German Burker company);Finnigan TSQ Quantum ultra AM Mass spectrograph (Finnigan company of the U.S.).
Embodiment 1, the synthesis of 13 Alpha-hydroxy -7- ketone -5 β-cholanic acid -24- methyl ester (III)
Take 2g (5.1mmol) chenodeoxycholic acid (I), 1.3g (7.3mmol) N-bromosuccinimide is justified in 100mL single port In the flask of bottom, add 48mL acetone-water (3:1, volume ratio), stirring reaction 4h under room temperature, finish through TLC detection reaction.To burning Add 10mL 20% (mass fraction) sodium sulfite in bottle, be evaporated acetone, then use 5mL hydrochloric acid solution (5%) to be acidified, treat Solid filters after separating out, and filtering residue is washed to neutrality, is dried, with re-dry after dehydrated alcohol recrystallization, obtains white solid 1.84g.
Take gained white solid in 150mL single necked round bottom flask, add 60mL methanol, be heated to 60 DEG C, Deca 1mL 98% concentrated sulphuric acid, return stirring reacts 12h, finishes through TLC detection reaction, adds 2g sodium bicarbonate, after bubble-free generates, mistake Filter excess bicarbonate, filtrate revolving is removed most of methanol, remaining liq is extracted with ethyl acetate, and is evaporated acetic acid second Ester, obtains white solid 1.66g and is compound (III), yield 91%.1H NMR(CDCl3,500MHz)δ:0.65 (3H, s, 18-CH3), 0.80 (3H, s, 19-CH3), 0.95 (3H, s, 21-CH3), 3.57 (1H, m, 3-CH) 3.65 (3H, s ,-CO2CH3).
In the oxidation reaction of this example, be respectively adopted NBS, PCC, chromic acid, DMSO/ oxalyl chloride, potassium permanganate be oxygen Agent, the consumption of oxidant is 1.5 times of the amount of compound (I) material, and other conditions are identical with this example, investigates different oxidations The impact to product for the agent, the results are shown in Table 1.
Table 1
Embodiment 2,3 α, the synthesis of 7- bis- (tert-butyl group dimethylsilyloxy) -6- alkene -5 β-cholanic acid -24- methyl ester (IV)
Take 5g (12.4mmol) compound (III) in 150mL single necked round bottom flask, add the oxolane that 25mL is dried And dissolve, take 4.1g (27.3mmol) tert-butyl chloro-silicane and 2g (29.8mmol) imidazoles to be added slowly to be stirred continuously Solution in, take 10mL triethylamine to be slowly added into this solution after 0.5h, under room temperature after all adding stir 4h, through TLC detection Reaction finishes.Add 25mL saturated solution of sodium bicarbonate in solution, be back to after room temperature after solution temperature, be extracted with ethyl acetate Organic faciess, after saturated brine washing, anhydrous sodium sulfate drying, revolving obtains brown oil solid 6.63g and is compound (IV), Yield 84%.1H NMR(CDCl3,500MHz)δ:0~0.2 (12H, m, 3,7-OSi (t-Bu) Me2), 0.66 (3H, s, 18- CH3), 0.70 (3H, s, 19-CH3), 0.92 (3H, s, 21-CH3), 3.50 (1H, m, 3-CH) 3.68 (3H, s ,-CO2CH3),4.70 (1H, dd, 6-CH).
In this example reaction, it is respectively adopted pyridine, triethylamine, DMA, triethanolamine, N, N- dimethyl methyl Amide is acid binding agent, and the consumption of acid binding agent is 2 times of the amount of compound (III) material, and other conditions are identical with this example reaction, Investigate the different impacts to product for the acid binding agent, the results are shown in Table 2.
Table 2
In this example reaction, the mole dosage ratio of adjustment triethylamine and formula III compound, other conditions are reacted with this example Identical, it is shown in Table 3 to the impact producing.
Table 3
In this example reaction, the mole dosage ratio of adjustment tert-butyl chloro-silicane and formula III compound, other Part is identical with this example reaction, and it is shown in Table 4 to the impact producing.
Table 4
Embodiment 3, the synthesis of 3 Alpha-hydroxy -6- ethylidene -7- ketone -5 β-cholanic acid -24- methyl ester (V)
Take 12.7g (23.2mmol) compound (IV) and dichloromethane (20mL) in 150mL single necked round bottom flask, cooling To -30 DEG C, add 1.7mL (0.121mol) paraldehydum to be stirred continuously, in stirring, be slowly added dropwise 2.2mL (0.09mol) trifluoro Change borate ether, after stirring lower reaction 1h, 0 DEG C can be warming up to.Then add dichloromethane 20mL in solution, be stirred overnight, warp TLC detection reaction finishes, and adds 6.5g (25mmol) tetrabutyl ammonium fluoride in solution, adds 50mL after stirring 1h in solution Stand after saturated solution of sodium bicarbonate, extract organic faciess with dichloromethane, saturated brine washs, anhydrous sodium sulfate drying, decompression Distillation, with rapid column chromatography (petroleum ether:Ethyl acetate=7:3, v/v) separately obtaining white solid 6.7g is compound (V), yield 67%.1H NMR(CDCl3,500MHz)δ:0.64 (3H, s, 18-CH3), 0.91 (3H, s, 19-CH3), 0.99 (3H, s, 21-CH3), 1.71 (3H, d, 2 '-CH3), 2.77 (1H, dd, 8-CH), 3.65 (3H, s ,-CO2CH3) 6.21 (1H, dd, 1’-CH).
In this example, it is respectively adopted aluminum chloride, iron chloride, zinc chloride and boron trifluoride diethyl etherate as Lewis acid, its consumption It is 4 times of formula IV compound mole, other conditions keep constant, test its impact to compound V yield, the results are shown in Table 5.
Table 5
Embodiment 4, the synthesis of 6- ethyl chenodeoxycholic acid (VI)
Take 3.0g (6.97mmol) compound (V) in 500mL autoclave, throw after adding the dissolving of 150mL glacial acetic acid Enter 0.5g palladium carbon, after extracting the air in container out, be passed through hydrogen exchange 2 times, more logical hydrogen is to 2atm, stirring is lower to react 12h.Instead Palladium carbon should be filtered to remove after stopping, solution is concentrated, mixed liquor is dissolved in water and the mixture of ethyl acetate, uses unsaturated carbonate Hydrogen sodium solution washs, and aqueous phase is extracted with ethyl acetate, saturated brine washing after two organic faciess mixing, and anhydrous sodium sulfate drying subtracts Pressure distillation.
Product is dissolved in 50mL methanol, adds 1.5g sodium borohydride, under room temperature, stir 2h, add acetic acid stopped reaction, After ethyl acetate extraction product, washing, it is dried, vacuum distillation concentrates, rapid column chromatography (petroleum ether:Ethyl acetate=1:1, v/ V) separate and obtain viscous brown shape solid 2.53g.
Products therefrom is dissolved in 20mL methanol, adds 0.5g sodium hydroxide and 5mL water, be stirred at reflux reaction 5h, will be molten After liquid concentrates, it is slowly added into 5% hydrochloric acid acidifying, filter after solid separates out, filter cake is washed with water to neutrality, after being dried, use second Acetoacetic ester recrystallization, obtains white solid 2.45g, yield 83%.M.p.108~110 DEG C;1H NMR(CDCl3,500MHz)δ: 0.56 (3H, s, 18-CH3), 0.72 (3H, t, 6-CH2CH3), 2.20 (2H, m, 23-CH2), 3.11 (1H, m, 7-CH) 3.44 (1H, m, 3-CH).MS,m/z:420.6.
Reduction reaction is respectively adopted the sodium borohydride of 6 times of Formula V compound moles, potassium borohydride, lithium aluminium hydride reduction and Stannous chloride is reducing agent, and other conditions are prepared the reaction of Formula IV compound using the same method of this example, divide to Formula IV The yield of compound is as shown in table 6.
Table 6
Sodium borohydride is adopted to be reducing agent in reduction reaction, the mol ratio of adjustment sodium borohydride and Formula V compound respectively, Other conditions are prepared the reaction of Formula IV compound using the same method of this example, divide the yield such as table 7 to Formula IV compound Shown.
Table 7

Claims (12)

1. a kind of synthetic method of Austria shellfish cholic acid is it is characterised in that it comprises the steps:
(1) chenodeoxycholic acid and oxidant carry out oxidation reaction and obtain compound (II), then carry out esterification and prepare formula III Compound 3 α-carboxyl -7 ketone -5 β cholestane -24- acid methyl ester;
(2) formula III compound and tert-butyl chloro-silicane and imidazoles in the presence of acid binding agent triethylamine to formula III chemical combination Hydroxyl on thing ring and carbonyl carry out protection and obtain formula IV compound;
(3) formula IV compound and paraldehydum carry out electrophilic addition reaction, then obtain after deprotection Formula V compound 3 Alpha-hydroxy- 6- ethylidene -7- ketone -5 β-cholanic acid -24- methyl ester;
(4) Formula V compound carries out catalytic hydrogenation, finally carries out reduction and hydrolysis obtain Formula IV compound Austria shellfish cholic acid;
2. method according to claim 1 is it is characterised in that in step (1), described oxidant be selected from NBS, PCC, three One or more of chromium oxide;The temperature of oxidation reaction is 20~30 DEG C.
3. method according to claim 2 is it is characterised in that in step (1), described oxidant is selected from NBS.
4. method according to claim 1 is it is characterised in that in step (1), chenodeoxycholic acid and oxidant mole Than for 1:1~2.
5. method according to claim 4 is it is characterised in that in step (1), chenodeoxycholic acid and oxidant mole Than for 1:1.5.
6. method according to claim 1 is it is characterised in that in step (1), esterification compound of formula H and first Alcohol carries out esterification, adds sulphuric acid in reaction, and reaction temperature is 55~65 DEG C.
7. method according to claim 1 is it is characterised in that in step (2), acid binding agent and compound III mole with Amount ratio is 1.6~2.5:1;Formula III compound is 1 with the mol ratio of tert-butyl chloro-silicane:1.5~3.5.
8. method according to claim 7 is it is characterised in that in step (2), acid binding agent and compound III mole with Amount ratio is 2:1;Formula III compound is 1 with the mol ratio of tert-butyl chloro-silicane:2~3.
9. method according to claim 1 is it is characterised in that in step (3), formula IV compound and paraldehydum and three Fluorination borate ether carries out electrophilic addition reaction at -35~0 DEG C, adds tetrabutyl ammonium fluoride to carry out at 0~30 DEG C after reaction Deprotection reaction, obtains Formula V compound.
10. method according to claim 1 is it is characterised in that in step (4), Formula V compound enters under palladium carbon catalysis Row hydrogenation reaction, carries out reduction reaction after hydrogenation reaction in the presence of reducing agent, is eventually adding sodium hydroxide and is hydrolyzed instead Should, obtain shellfish cholic acid difficult to understand.
11. methods according to claim 10 are it is characterised in that in step (4), hydrogenation reaction temperature is 20~30 DEG C; Reducing agent is selected from sodium borohydride, potassium borohydride, stannous chloride or lithium aluminium hydride reduction, and reduction reaction temperature is 20~30 DEG C, Formula V chemical combination Thing is 1 with the mol ratio of reducing agent:5~8;Hydrolysising reacting temperature is 90~110 DEG C.
12. methods according to claim 11 are it is characterised in that in step (4), hydrogenation reaction temperature is 20~30 DEG C; Reducing agent is selected from sodium borohydride, and Formula V compound is 1 with the mol ratio of reducing agent:6.
CN201610394654.6A 2016-06-06 2016-06-06 Synthetic method of 6-ethylchenodeoxycholic acid Active CN106046095B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610394654.6A CN106046095B (en) 2016-06-06 2016-06-06 Synthetic method of 6-ethylchenodeoxycholic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610394654.6A CN106046095B (en) 2016-06-06 2016-06-06 Synthetic method of 6-ethylchenodeoxycholic acid

Publications (2)

Publication Number Publication Date
CN106046095A CN106046095A (en) 2016-10-26
CN106046095B true CN106046095B (en) 2017-02-22

Family

ID=57170299

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610394654.6A Active CN106046095B (en) 2016-06-06 2016-06-06 Synthetic method of 6-ethylchenodeoxycholic acid

Country Status (1)

Country Link
CN (1) CN106046095B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106397522A (en) * 2015-07-31 2017-02-15 中国人民解放军军事医学科学院毒物药物研究所 3,7-di(t-butyldimethylsiloxy)-6-ene-5beta-cholan-24-oic acid methyl ester
TW201738254A (en) 2016-04-19 2017-11-01 英特賽普醫藥品公司 Methods for the preparation of obeticholic acid and derivatives thereof
CN108239134B (en) * 2016-12-23 2020-07-07 上海博邦医药科技有限公司 Obeticholic acid intermediate and preparation method and application thereof
US11053275B2 (en) 2017-04-20 2021-07-06 Daewoong Bio Inc. Method for bile acid derivative by using continuous flow reaction
CN108948117B (en) * 2017-05-19 2020-09-18 杭州源昶医药科技有限公司 Synthetic method of obeticholic acid
CN107955056A (en) * 2017-12-06 2018-04-24 南京法恩化学有限公司 A kind of synthetic method of Austria's shellfish cholic acid and intermediate
CN111718388A (en) * 2019-03-19 2020-09-29 苏州泽璟生物制药股份有限公司 Preparation method of chenodeoxycholic acid derivative

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104853758A (en) * 2012-11-28 2015-08-19 英特赛普特医药品公司 Treatment of pulmonary disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104853758A (en) * 2012-11-28 2015-08-19 英特赛普特医药品公司 Treatment of pulmonary disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Design, Synthesis, and Biological Evaluation of Potent Receptors;Claudio D’Amore等;《Journal of Medicinal Chemistry》;20140104;第57卷(第3期);第937-954页,参见第939页scheme 1 *

Also Published As

Publication number Publication date
CN106046095A (en) 2016-10-26

Similar Documents

Publication Publication Date Title
CN106046095B (en) Synthetic method of 6-ethylchenodeoxycholic acid
Marshall et al. Reduction of steroidal enamines
CN108676049A (en) A kind of preparation method of Austria's shellfish cholic acid, ursodesoxycholic acid and 7- Ketocholic acid
CN114524856B (en) Synthesis method of high-purity plant-derived cholesterol
CN114395009B (en) High-purity cholesterol synthesis method
CN107245089A (en) A kind of preparation method of shellfish cholic acid difficult to understand
CN107955058A (en) A kind of preparation of the intermediate for being used to prepare shellfish cholic acid difficult to understand, its preparation method and shellfish cholic acid difficult to understand
CN103396464B (en) A kind of preparation method of ivermectin
CN102633763B (en) Preparation method of (S)-equol
CN107400154A (en) One kind prepares 3 α, the method for the 7 α-α of bis-hydroxy-6-β of ethyl-5-cholanic acid
CN103739604A (en) Preparation method of Pralatrexate suitable for industrial large scale production
CN108586355A (en) A kind of process for purification of olaparib
CN107235937A (en) A kind of synthetic method of (S) 3 hydroxyl tetrahydrofuran
CN110317129A (en) The synthetic method of the bromo- 5- metoxyphenol of 2-
EP3744711A1 (en) Method for preparing mesaconine and related intermediaries
CN113004300B (en) Stable isotope labeled patulin and synthesis method thereof
CN108239019B (en) Synthesis method of (2S,5S or 5R) -N-tert-butyloxycarbonyl-5-hydroxy-2-ethyl piperidinecarboxylate
CN115466300A (en) Cholic acid intermediate A7 and synthesis method thereof
CN104725460A (en) Preparation method of androst-4-ene-6beta,19-epoxy-3,17-dione
CN107353256A (en) The method of the triazole compounds of 4 acetyl group of one pot process 1,2,3
CN113264850A (en) Synthetic method of nootropic ketonic A
WO2023000636A1 (en) Method for synthesis of (3-fluorooxetan-3-yl)methyl 4-methylbenzenesulfonate
CN107216335A (en) The formic acid base ester preparation method of 3 oxa- of a kind of tert-butyl group 1 (methylol) 9 azaspiro [5.5] hendecane 9
CN108659086A (en) A kind of synthetic method of Austria's shellfish cholic acid
CN101012264A (en) Method of synthesizing pig ectohormone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant